换一批Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone.
第一作者：
M A,Dimopoulos
第一单位：
Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece.
作者：
医学主题词
血管生成抑制剂(Angiogenesis Inhibitors);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);克拉霉素(Clarithromycin);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);地塞米松(Dexamethasone);人类(Humans);沙立度胺(Thalidomide);Waldenstrom巨球蛋白血症(Waldenstrom Macroglobulinemia)
DOI
10.1053/sonc.2003.50079
PMID
12720150
发布时间
2013-11-21
- 浏览4
Seminars in oncology
265-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
